OVERVIEW

Clinical Vignette Series: 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Activity Overview:
In Clinical Vignette Series: 37th Annual Chemotherapy Foundation Symposium (CFS®): Innovative Cancer Therapy for Tomorrow®, oncology thought leaders address clinical challenges faced by community oncologists, like you, and offer their insight and commentary on the clinical application of new data and advances. This interactive, online activity features a series of case-based vignettes, self-reflection questions, and brief audio-video clips in which the program faculty share their approaches and answer other related questions. This activity touches on established and emerging standards of care in multiple myeloma, as well as cancers of the breast, lung, kidney, pancreas, and liver. It is based on content presented at the 2019 CFS® meeting. This annual gathering has a longstanding history of providing education, guidance, perspectives, and solutions to practicing oncologists. Delivering state-of-the-art cancer care requires incorporation of new clinical advances and data into practice. Across all cancer types, improvements in patient outcomes are being driven by novel approaches in testing, systemic therapy, targeted therapy and immunotherapies, and combination strategies. This online activity provides an unparalleled opportunity to learn new methods of optimizing and personalizing care for your patients with cancer.

Benefits of Participating:
• Incorporate the latest clinical data and evidence-based strategies into your practice
• Learn experts’ viewpoints on areas of clinical uncertainty

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Review key testing strategies across tumor types for identification of tumor markers for prognostic/predictive assessment and selection of appropriate treatment.
• Recognize practice-changing results to inform improved diagnosis, treatment, and adverse event management across solid and liquid tumors.
• Identify ways of translating novel evidence-based treatment strategies using immunotherapeutic, targeted treatment, and chemotherapeutic treatment strategies into clinical practice.
• Learn strategies for promoting multidisciplinary best practices in the proactive management of treatment-related toxicities.
• Analyze practice-changing evidence presented at major conferences and apply these findings to improve the treatment of patients with cancer.